All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | TCR Clone | Host Species | Epitope | Allele | Vector Type | Inquiry & Datasheet |
TCR-YC1204 | Human anti-TRPV4 T cell receptor (AD6), pCDTCR1 | Human | AD6 | Human | YLLFMIGYA | HLA-A2 | Lentiviral vector | |
TCR-YC1205 | Human anti-TRPV4 T cell receptor (AH5), pCDTCR1 | Human | AH5 | Human | YLLFMIGYA | HLA-A2 | Lentiviral vector | |
TCR-YC1206 | Human anti-TRPV4 T cell receptor (BD4), pCDTCR1 | Human | BD4 | Human | YLLFMIGYA | HLA-A2 | Lentiviral vector | |
TCR-YC1207 | Human anti-TRPV4 T cell receptor (BF4), pCDTCR1 | Human | BF4 | Human | FMIGYASAL | HLA-A2 | Lentiviral vector | |
TCR-YC1208 | Human anti-TRPV4 T cell receptor (FA11), pCDTCR1 | FA11 | Human | FMIGYTSAL | HLA-A2 | Lentiviral vector | ||
TCR-YC1209 | Human anti-TRPV4 T cell receptor (FF4), pCDTCR1 | FF4 | Human | FMIGYTSAL | HLA-A2 | Lentiviral vector | ||
TCR-YC1210 | Human anti-TRPV4 T cell receptor (FF7), pCDTCR1 | FF7 | Human | FMIGYTSAL | HLA-A2 | Lentiviral vector | ||
TCR-YC1211 | Human anti-TRPV4 T cell receptor ((FG2)-1), pCDTCR1 | Human | FG2 | Human | FMIGYASAL | HLA-A2 | Lentiviral vector | |
TCR-YC1212 | Human anti-TRPV4 T cell receptor ((FG2)-2), pCDTCR1 | FG2 | Human | FMIGYTSAL | HLA-A2 | Lentiviral vector | ||
TCR-YC1213 | Human anti-TRPV4 T cell receptor (GF7), pCDTCR1 | Human | GF7 | Human | YLLFMIGYA | HLA-A2 | Lentiviral vector | |
TCR-YC1214 | Human anti-TRPV4 T cell receptor (JG11), pCDTCR1 | JG11 | Human | FMIGYTSAL | HLA-A2 | Lentiviral vector | ||
TCR-YC1215 | Human anti-TRPV4 T cell receptor ((LG2)-1), pCDTCR1 | Human | LG2 | Human | FMIGYASAL | HLA-A2 | Lentiviral vector | |
TCR-YC1216 | Human anti-TRPV4 T cell receptor ((LG2)-2), pCDTCR1 | LG2 | Human | FMIGYTSAL | HLA-A2 | Lentiviral vector |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION